Salisbury VA Medical Center | Salisbury, NC
Status
Conditions
Treatments
About
The study objective is to evaluate the safety of the iTind device comparied to UroLift.
Full description
UroLift is a treatment for relieving lower urinary tract symptoms (LUTS) secondary to benign Prostatic Hyperplasia (BPH) as a minimally invasive procedure. This procedure has proven to have high efficacy with regards to improving objective and subjective parameters. The iTind is a minimally invasive temporary device designed to relieve LUTS secondary to BPH. This study is designed to compare the minimally invasive iTind device to UroLift.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
206 participants in 2 patient groups
Loading...
Central trial contact
Selen ZuelbaharOlgun, PhD; Meaghan Dunn, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal